# STOCKHOLM 1.0
#=GF ID   Tachystatin_A
#=GF AC   PF11406.12
#=GF DE   Antimicrobial peptide tachystatin A
#=GF AU   Pollington J;0000-0002-8158-8998
#=GF SE   pdb_1cix
#=GF GA   25.00 25.00;
#=GF TC   25.10 25.10;
#=GF NC   24.80 24.80;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 -E 1000 --cpu 4 HMM pfamseq
#=GF TP   Family
#=GF WK   Tachystatin
#=GF CL   CL0083
#=GF RN   [1]
#=GF RM   11959852
#=GF RT   Structure of the antimicrobial peptide tachystatin A. 
#=GF RA   Fujitani N, Kawabata S, Osaki T, Kumaki Y, Demura M, Nitta K,
#=GF RA   Kawano K; 
#=GF RL   J Biol Chem. 2002;277:23651-23657.
#=GF DR   INTERPRO; IPR022717;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   Tachystatin A contains a cysteine-stabilised triple-stranded
#=GF CC   beta-sheet and shows features common to membrane-interactive
#=GF CC   peptides. Tachystatin A is thought to have an antimicrobial
#=GF CC   activity similar to defensins.Tachystatin A is also a
#=GF CC   chitin-binding peptide [1].
#=GF SQ   2
#=GS TACA2_TACTR/24-67  AC Q9U8X3.1
#=GS TACA1_TACTR/1-44   AC P0C1Z7.1
TACA2_TACTR/24-67             YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY
TACA1_TACTR/1-44              YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRF
#=GC seq_cons                 YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRa
